Literature DB >> 15133708

[Stability of postoperative visual acuity after rt-PA -SF6-treatment of submacular hemorrhage in age-related macular degeneration].

A Steller1, E Gerke.   

Abstract

PURPOSE: Treatment of submacular hemorrhage with recombinant tissue plasminogen activator(rt-PA) and SF6 induces blood displacement out of the fovea by maintaining prone positioning. The underlying disease, e.g. the choroidal neovascularisation remains untreated. Nevertheless, it has been noted that the visual results of this method are more favorable than those expected in the natural course. Contributing long-term results the present study intends to give more information concerning this phenomenon.
METHOD: A total of 45 consecutive eyes were treated using a standardized procedure (duration of hemorrhage < or =1 week, area of hemorrhage 1-10 disc areas, 50 gammag rt-PA, 0.5 ml SF6 24 h later, prone positioning for 3 days). Those with a follow-up of > or =6 months were included in the study.
RESULTS: From 25 patients a total of 25 eyes fulfilled the criteria. Postoperative visual acuity(3-7 days) was improved or unchanged in 19 eyes and worse in 6 eyes. Comparison of postoperative visual acuity after follow-up of an average of 14.2 months (range 6-28 months) revealed an improvement in 10 eyes, no change in 7 eyes and a deterioration in 8 eyes. A second treatment was performed in 2 eyes and photocoagulation in 1 eye.
CONCLUSION: After more than 1 year the postoperative visual acuity was stable or even better in about two-thirds of the eyes therefore treatment with rt-PA and SF6 may also influence the choroidal neovascularisation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133708     DOI: 10.1007/s00347-003-0924-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  6 in total

1.  [Clinical results of intravitreal administration of tissue-type plasminogen activator (tPA) and gas for removal of subretinal hemorrhage in senile macular degeneration].

Authors:  C Framme; H E Toukhy; H G Sachs; D Spiegel; J Roider; V P Gabel; C P Lohmann
Journal:  Klin Monbl Augenheilkd       Date:  2000-01       Impact factor: 0.700

2.  Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions.

Authors:  L O Hattenbach; C Klais; F H Koch; H O Gümbel
Journal:  Ophthalmology       Date:  2001-08       Impact factor: 12.079

3.  Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas.

Authors:  L Hesse; J Schmidt; P Kroll
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1999-04       Impact factor: 3.117

4.  Effect of intravitreal tissue plasminogen activator on experimental subretinal hemorrhage.

Authors:  G E Coll; J R Sparrow; A Marinovic; S Chang
Journal:  Retina       Date:  1995       Impact factor: 4.256

5.  Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.

Authors:  A S Hassan; M W Johnson; T E Schneiderman; C D Regillo; P E Tornambe; L S Poliner; B A Blodi; S G Elner
Journal:  Ophthalmology       Date:  1999-10       Impact factor: 12.079

6.  [Intravitreal injection of rt-PA and gas in the management of minor submacular haemorrhages secondary to age-related macular degeneration].

Authors:  Lars-Olof Hattenbach; Marion Brieden; Frank Koch; Hermann Gümbel
Journal:  Klin Monbl Augenheilkd       Date:  2002-07       Impact factor: 0.700

  6 in total
  3 in total

1.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

2.  Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement.

Authors:  John T Thompson; Raymond N Sjaarda
Journal:  Trans Am Ophthalmol Soc       Date:  2005

3.  Visual Outcome after Vitrectomy with Subretinal tPA Injection to Treat Submacular Hemorrhage Secondary to Age-Related Macular Degeneration or Macroaneurysm.

Authors:  Yasmin Ali Said; Evelien Dewilde; Peter Stalmans
Journal:  J Ophthalmol       Date:  2021-12-30       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.